KYMERA THERAPEUTICS INC (KYMR)

US5015751044 - Common Stock

38.3  +0.9 (+2.41%)

After market: 38.3 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
78.59M46.83M72.83M34.03M2.93M
Operating Expenses
244.12M208.08M173.36M80.34M45.14M
Research and Development
189.08M164.25M137.02M62.11M37.16M
Selling, General, and Administrative Expenses
55.04M43.83M36.35M18.23M7.98M
Operating Income
-165.53M-161.26M-100.53M-46.30M-42.21M
Interest Income/Expense
18.57M6.45M310.00K710.00K960.00K
Income Before Taxes
-146.96M-154.81M-100.22M-45.59M-41.25M
Net Income
-146.96M-154.81M-100.22M-54.64M-41.25M
EBITDA
-161.97M-158.28M-98.13M-44.54M-41.38M
 
Per Share Data
EPS Diluted Total Ops
-2.52-2.87-2.09-1.23-0.96
Non GAAP EPS
-2.52-2.88-2.06N/AN/A
 
Statistics
Profit Margin
-186.99%-330.58%-137.61%-160.56%-1407.85%
Operating Profit Margin
-210.62%-344.35%-138.03%-136.06%-1440.61%

All data in USD

Charts